BG62912B1 - Фармацевтичен или ветеринарен състав, съдържащ мупироцин или негова сол - Google Patents
Фармацевтичен или ветеринарен състав, съдържащ мупироцин или негова сол Download PDFInfo
- Publication number
- BG62912B1 BG62912B1 BG100501A BG10050196A BG62912B1 BG 62912 B1 BG62912 B1 BG 62912B1 BG 100501 A BG100501 A BG 100501A BG 10050196 A BG10050196 A BG 10050196A BG 62912 B1 BG62912 B1 BG 62912B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- weight
- composition according
- composition
- salt
- mupirocin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939321876A GB9321876D0 (en) | 1993-10-22 | 1993-10-22 | Novel composition |
| GB939322288A GB9322288D0 (en) | 1993-10-29 | 1993-10-29 | Novel composition |
| PCT/US1994/012026 WO1995010999A1 (en) | 1993-10-22 | 1994-10-20 | Novel composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG100501A BG100501A (bg) | 1996-12-31 |
| BG62912B1 true BG62912B1 (bg) | 2000-11-30 |
Family
ID=26303736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG100501A BG62912B1 (bg) | 1993-10-22 | 1996-04-12 | Фармацевтичен или ветеринарен състав, съдържащ мупироцин или негова сол |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6025389A (de) |
| EP (1) | EP0727979B1 (de) |
| JP (1) | JPH09506865A (de) |
| KR (1) | KR100374462B1 (de) |
| CN (1) | CN1102410C (de) |
| AP (1) | AP608A (de) |
| AT (1) | ATE202467T1 (de) |
| AU (1) | AU692486B2 (de) |
| BG (1) | BG62912B1 (de) |
| BR (1) | BR9407840A (de) |
| CA (1) | CA2174658C (de) |
| CZ (1) | CZ292223B6 (de) |
| DE (1) | DE69427589T2 (de) |
| DK (1) | DK0727979T3 (de) |
| ES (1) | ES2157996T3 (de) |
| FI (1) | FI116931B (de) |
| GR (1) | GR3036591T3 (de) |
| HK (1) | HK1012284A1 (de) |
| HU (1) | HU221853B1 (de) |
| NO (1) | NO313446B1 (de) |
| NZ (1) | NZ275282A (de) |
| OA (1) | OA10361A (de) |
| PL (1) | PL177592B1 (de) |
| PT (1) | PT727979E (de) |
| RO (1) | RO112987B1 (de) |
| SK (1) | SK280222B6 (de) |
| UA (1) | UA39896C2 (de) |
| WO (1) | WO1995010999A1 (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR199900733T2 (xx) * | 1996-10-01 | 1999-07-21 | Smithkline Beecham Corporation | Patojenik organizmalar ile nasofarinksin kolonizasyonu ile ilgili bakteriyal enfeksiyonlar�n tedavisi i�in bir ilac�n imalat�nda mupirosin kullan�m�. |
| CO4910145A1 (es) * | 1996-10-01 | 2000-04-24 | Smithkline Beecham Corp | Uso |
| CA2303443A1 (en) * | 1997-09-11 | 1999-03-18 | Anthony Guy Hatton | Compositions adapted for prolonged residence in the nasal pharynx |
| IL123143A (en) * | 1998-02-02 | 2001-08-26 | Agis Ind 1983 Ltd | Pharmaceutical compositions containing mupirocin |
| GB9808470D0 (en) | 1998-04-22 | 1998-06-17 | Smithkline Beecham Plc | Novel process and apparatus |
| IL137363A (en) * | 2000-07-18 | 2005-12-18 | Agis Ind 1983 Ltd | Pharmaceutical compositions containing mupirocin |
| IL150907A (en) * | 2002-07-25 | 2007-07-04 | Stephan Cherkez | Process for the preparation of stable amorphous calcium pseudomonate |
| US20040224981A1 (en) * | 2003-05-01 | 2004-11-11 | Nebojsa Janjic | Antibacterial methods and compositions |
| US20050123575A1 (en) * | 2003-12-03 | 2005-06-09 | Eilon Asculai | Spreadable compositions for topical use, an improved process of making same and methods of using same |
| WO2008007182A2 (en) * | 2006-07-07 | 2008-01-17 | Glenmark Pharmaceuticals Limited | Topical pharmaceutical compositions of mupirocin or pharmaceutically acceptable salts or esters thereof |
| CN102933212B (zh) | 2010-03-30 | 2015-07-22 | 赫尔普百治疗有限公司 | 组合及应用 |
| CA2807075C (en) | 2010-08-05 | 2018-10-16 | Helperby Therapeutics Limited | Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine |
| GB201013207D0 (en) | 2010-08-05 | 2010-09-22 | Helperby Therapeutics Ltd | Novel combination |
| GB201015079D0 (en) | 2010-09-10 | 2010-10-27 | Helperby Therapeutics Ltd | Novel use |
| US20130245060A1 (en) | 2010-10-08 | 2013-09-19 | Helperby Therapeutics Limited | Novel composition |
| PL2704704T3 (pl) | 2011-05-03 | 2019-04-30 | Dupont Nutrition Biosci Aps | Bakterie probiotyczne do miejscowego leczenia zaburzeń skóry |
| GB201107755D0 (en) | 2011-05-10 | 2011-06-22 | Helperby Therapeutics Ltd | Novel compounds |
| CN102335122B (zh) * | 2011-06-21 | 2013-04-17 | 北京协和药厂 | 一种莫匹罗星软膏及其制备方法 |
| DE102012215511A1 (de) | 2012-08-31 | 2014-06-12 | Schülke & Mayr GmbH | Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung |
| GB201305277D0 (en) | 2013-03-22 | 2013-05-01 | Helperby Therapeutics Ltd | Novel combination and use |
| GB201307989D0 (en) | 2013-05-02 | 2013-06-12 | Helperby Therapeutics Ltd | Novel combinations and use |
| ES2967618T3 (es) | 2013-12-17 | 2024-05-03 | Hatchtech Pty Ltd | Composición pediculicida |
| GB201401617D0 (en) | 2014-01-30 | 2014-03-19 | Helperby Therapeutics Ltd | Novel combination and use |
| CN107530397A (zh) | 2014-12-18 | 2018-01-02 | 赫尔普百治疗有限公司 | 新型组合和用途 |
| WO2016133471A1 (en) | 2015-02-20 | 2016-08-25 | Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. | A topical composition comprising mupirocin and dexpanthenol |
| GB201518969D0 (en) | 2015-10-27 | 2015-12-09 | Helperby Therapeutics Ltd | Triple combination |
| WO2017184601A1 (en) | 2016-04-19 | 2017-10-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Use of gram negative species to treat atopic dermatitis |
| US10293005B2 (en) | 2016-04-19 | 2019-05-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Use of gram negative species to treat atopic dermatitis |
| GB201610869D0 (en) | 2016-06-22 | 2016-08-03 | Helperby Therapeutics Ltd | Combination |
| GB201620095D0 (en) | 2016-11-28 | 2017-01-11 | Terali Innov Sas And Univ De Strasbourg And Inserm (Inst Nat De La Sante Et De La Rech Medicale) And | Novel use |
| GB201709193D0 (en) | 2017-06-09 | 2017-07-26 | Helperby Therapeutics Ltd | Combination |
| WO2019141957A1 (en) | 2018-01-19 | 2019-07-25 | Cado Biotechnology Ivs | N-pyrimidinyl hydroxy pyrazole derivatives and uses thereof |
| US10973841B2 (en) | 2018-05-11 | 2021-04-13 | Forte Subsidiary, Inc. | Compositions for the treatment of skin conditions |
| WO2020081109A1 (en) * | 2018-10-17 | 2020-04-23 | Glenmark Pharmaceuticals Inc., Usa | Mupirocin cream in pump device |
| IL271778A (en) | 2019-12-31 | 2021-06-30 | Ichilov Tech Ltd | Methods for treating atopic dermatitis |
| US20210299019A1 (en) * | 2020-03-31 | 2021-09-30 | Chemistryrx | Methods for treating hyperpigmentation and compositions for same |
| WO2022207721A1 (en) | 2021-03-30 | 2022-10-06 | Dupont Nutrition Biosciences Aps | Compositions and methods for treating and preventing gastrointestinal inflammation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3758686A (en) * | 1971-12-07 | 1973-09-11 | American Cyanamid Co | Method of using steroid acetonides |
| US3934013A (en) * | 1975-02-21 | 1976-01-20 | Syntex (U.S.A.) Inc. | Pharmaceutical composition |
| NZ200918A (en) * | 1981-07-02 | 1985-07-31 | Gist Brocades Nv | Stable fatty oil-in-water emulsion cream for topical application |
| GB8530796D0 (en) * | 1985-12-13 | 1986-01-22 | Beecham Group Plc | Pharmaceutical composition |
| IE59628B1 (en) * | 1986-06-26 | 1994-03-09 | Beecham Group Plc | Treatment of fungal infections |
| US4847068A (en) * | 1987-08-06 | 1989-07-11 | Johnson & Johnson Consumer Products, Inc. | Skin care compositions |
-
1994
- 1994-10-20 PT PT94931943T patent/PT727979E/pt unknown
- 1994-10-20 DK DK94931943T patent/DK0727979T3/da active
- 1994-10-20 SK SK495-96A patent/SK280222B6/sk not_active IP Right Cessation
- 1994-10-20 JP JP7512208A patent/JPH09506865A/ja active Pending
- 1994-10-20 CA CA002174658A patent/CA2174658C/en not_active Expired - Lifetime
- 1994-10-20 EP EP94931943A patent/EP0727979B1/de not_active Expired - Lifetime
- 1994-10-20 AP APAP/P/1996/000798A patent/AP608A/en active
- 1994-10-20 CN CN94194238A patent/CN1102410C/zh not_active Expired - Lifetime
- 1994-10-20 DE DE69427589T patent/DE69427589T2/de not_active Expired - Lifetime
- 1994-10-20 WO PCT/US1994/012026 patent/WO1995010999A1/en active IP Right Grant
- 1994-10-20 AT AT94931943T patent/ATE202467T1/de active
- 1994-10-20 KR KR1019960702041A patent/KR100374462B1/ko not_active IP Right Cessation
- 1994-10-20 UA UA96041570A patent/UA39896C2/uk unknown
- 1994-10-20 PL PL94314038A patent/PL177592B1/pl unknown
- 1994-10-20 HU HU9601030A patent/HU221853B1/hu active IP Right Grant
- 1994-10-20 RO RO96-00817A patent/RO112987B1/ro unknown
- 1994-10-20 BR BR9407840A patent/BR9407840A/pt not_active Application Discontinuation
- 1994-10-20 NZ NZ275282A patent/NZ275282A/en not_active IP Right Cessation
- 1994-10-20 ES ES94931943T patent/ES2157996T3/es not_active Expired - Lifetime
- 1994-10-20 CZ CZ19961120A patent/CZ292223B6/cs not_active IP Right Cessation
- 1994-10-20 AU AU80847/94A patent/AU692486B2/en not_active Expired
-
1996
- 1996-04-12 BG BG100501A patent/BG62912B1/bg unknown
- 1996-04-19 NO NO19961588A patent/NO313446B1/no not_active IP Right Cessation
- 1996-04-19 FI FI961720A patent/FI116931B/fi not_active IP Right Cessation
- 1996-04-22 OA OA60817A patent/OA10361A/en unknown
-
1997
- 1997-07-25 US US08/903,255 patent/US6025389A/en not_active Expired - Lifetime
-
1998
- 1998-12-16 HK HK98113614A patent/HK1012284A1/xx not_active IP Right Cessation
-
2001
- 2001-09-11 GR GR20010401448T patent/GR3036591T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG62912B1 (bg) | Фармацевтичен или ветеринарен състав, съдържащ мупироцин или негова сол | |
| US4808610A (en) | Mometasone furoate anti-inflammatory cream composition using hexylene glycol | |
| SK11993A3 (en) | External preparation containing cyclosporin | |
| CZ285679B6 (cs) | Farmaceutický a kosmetický prostředek k místnímu nanášení na pokožku a způsob jeho přípravy | |
| JPS6321648B2 (de) | ||
| US5538989A (en) | Fenbendazole formulations | |
| AU2001276567B2 (en) | Antifungal ketoconazole composition for topical use | |
| EP0445540B1 (de) | Antimykotische Imidazol enthaltende Zubereitung zur äusserlichen Anwendung | |
| AU2001276567A1 (en) | Antifungal ketoconazole composition for topical use | |
| RU2148998C1 (ru) | Фармацевтическая или ветеринарная композиция (варианты) и способ получения композиции | |
| US20230330113A1 (en) | Topical composition | |
| EP0056681A2 (de) | Formulierungen des Levonantradols und N-Methyllevonantradols | |
| KR101829049B1 (ko) | 비타민 d 유사체와 코르티코스테로이드를 포함하는 개선된 안정성을 갖는 약학 조성물 | |
| CZ269293A3 (en) | Medicinal ointment without skin irritating effect and process for preparing thereof |